Relapsed Childhood T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

Researchers summarize the present state of understanding of the risk factors for relapse of T-acute lymphoblastic leukemia/lymphoblastic lymphoma, established treatment regimens, and the promising small molecule inhibitors and immunotherapies with the potential to revolutionize their treatment.